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Summary In this paper the psychometric properties of the multidimensional fatigue inventory (MFI-20) are
established further in cancer patients. The MFI is a 20-item self-report instrument designed to measure fatigue.
It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation and
mental fatigue. The instrument was used in a Dutch and Scottish sample of cancer patients receiving
radiotherapy. The dimensional structure was assessed using confirmatory factor analyses (Lisrel's unweighted
least-squares method). The hypothesised five-factor model appeared to fit the data in both samples (adjusted
goodness of fit; AGFI: 0.97 and 0.98). Internal consistency of the separate scales was good in both the Dutch
and Scottish samples with Cronbach's alpha coefficients ranging from 0.79 to 0.93. Construct validity was
assessed by correlating the MFI-20 to activities of daily living, anxiety and depression. Significant relations
were assumed. Convergent validity was investigated by correlating the MFI scales with a visual analogue scale
measuring fatigue and with a fatigue-scale derived from the Rotterdam Symptom Checklist. Results support
the validity of the MFI-20. The highly similar results in the Dutch and Scottish sample suggest that the
portrayal of fatigure using the MFI-20 is quite robust.
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Fatigue is probably the most frequently reported symptom of
patients with cancer. It can be experienced before diagnosis,
signalling to the individual the possibility of disease.
Following cancer diagnosis, treatments such as surgery,
radiotherapy or chemotherapy may induce fatigue. It is
estimated that about 70% of cancer patients experience
fatigue during radiotherapy and chemotherapy (Smets et al.,
1993). In general, fatigue decreases during the period of
convalescence. However, results have been reported indicat-
ing that some patients continue to experience a lack of energy
long after treatment has ended (Fobair et al., 1986; Devlen et
al., 1987; Berglund et al., 1991).
The possible consequences of fatigue are reflected in its
detrimental effect on activity level. In female chemotherapy
patients fatigue and weakness were the symptoms that
interfered most with self-care activities (Rhodes et al.,
1988). To limit the expenditure of energy, activities and
work were scheduled, non-essential activities were decreased
and patients reported an increasing dependence on others for
home management activities, including meal preparation,
grocery shopping and cleaning. In a similar sample, Jamar
(1989) found social activities to be decreased as a result of
fatigue. Some data suggest that loss of energy or physical
stamina affects the ability to work after treatment for cancer
(Fobair et al., 1986; Weis et al., 1992). Finally, Bloom and
colleagues (1990) found that in male patients treated for
Hodgkin's disease perceived energy level interacted with
leisure activities but not with work activity.
Studies investigating pyschological distress of cancer
patients suggest a relationship between fatigue and negative
affect. Fatigue was found to be significantly related to
negative mood (Jamar, 1989; Blesch et al., 1991) and to
emotional distress experienced during chemotherapy treat-
ment (Nerenz et al., 1982). Patients whose energy level had
not returned to normal after treatment for Hodgkin's disease
were also more likely to have elevated depression scores
(Fobair et al., 1986).
Despite its high prevalence and potential negative effect on
patients' activities and emotional well-being, research in
fatigue is still underdeveloped. Reliable and valid indicators
of fatigue are necessary to study this symptom.
Based on a review of instruments used in studies involving
cancer patients it was concluded that most measures of
fatigue in cancer are incorporated in instruments that
measure broader aspects of patient functioning (Smets et
al., 1993). Instruments that are more comprehensive and easy
to administer and that have been thoroughly tested for their
psychometric properties were found to be lacking. Therefore,
we developed a self-report instrument. Taking the position
that fatigue is a multidimensional concept, the questionnaire
was designed to cover the following dimensions: general
expressions of fatigue, physical fatigue, reduced activity,
reduced motivation and mental fatigue. These dimensions
were based on the manner in which fatigue can be expressed
as indicated in the literature and resulting from pilot in-depth
patient interviews. The use of a multidimensional instrument
offered the opportunity to obtain a profile of fatigue that
would give the most adequate description of the experience of
the respondents and that might discriminate between
populations, moments in time or factors contributing to the
fatigue experience. The procedure followed to develop the
questionnaire - The Multidimensional Fatigue Inventory
(MFI) - and the studies investigating its psychometric
properties in different populations have been reported in
detail elsewhere (Smets et al., 1995). Here, we give a brief
overview of these studies and their results.
The initial version was tested for its structure, internal
consistency and validity in a heterogeneous group of patients
receiving radiotherapy for cancer (n =111). The instrument
was tested in patients with chronic fatigue syndrome (CFS)
(n= 357), in psychology students (n=481) and medical
students (n = 158), in army recruits (n=316) and in junior
physicians (n =46). The factor structure of the MFI was
investigated using confirmatory factor analyses. Results
confirmed the proposed five dimensions of fatigue and a
similar five-factor solution was supported across all samples
tested. The internal consistency of the resulting five scales was
good with an average Cronbach's alpha coefficient of 0.80
(range: 0.53-0.93). Construct validity of the instrument was
determined by comparing groups with assumed differences in
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fatigue. For example, patients were expected to be more
fatigued than students; soldiers were expected to be more
fatigued during a physically intensive military training
programme than during their stay in the barrack and junior
physicians were expected to report more fatigue during
training in internal medicine than before this training period.
The scales for general and physical fatigue showed consistent
and distinct differences between and within groups according
to expectations. General fatigue especially, appeared to be
sensitive to predicted changes in fatigue level. The CFS
patients and cancer patients differed from the comparison
groups as expected on most scales. The scale for reduced
motivation behaved as expected in most tests. Finally, mental
fatigue seemed to differ somewhat from the other scales,
especially in the group of radiotherapy patients. Radio-
therapy patients scored lowest on mental fatigue as compared
with any of the other groups, which was contrary to
expectations (mean score= 10.06, s.d. = 6.1). Convergent
validity was assessed by correlating the MFI scales with the
scores on a visual analogue scale covering the intensity of
fatigue in the sample of radiotherapy patients. Correlations
were all significant, ranging from 0.77 for general fatigue
(P<0.001) to 0.23 for mental fatigue (P<0.01). Overall, the
psychometric properties of the instrument were promising.
Since our original purpose was to develop a fatigue
questionnaire to be used in cancer patient populations, the
MFI was tested in two additional investigations involving
Dutch and Scottish cancer patients treated with radiotherapy.
In this paper results are presented regarding the psychometric
properties of the MFI when used in cancer patients treated
with radiotherapy: its structure and internal consistency were
again assessed and additional information on its validity was
obtained. The application of the instrument in both a Dutch
and Scottish sample offered the opportunity of a cross-
cultural comparison.
Method
Subjects and data collection procedure
The Dutch sample involved patients in their last week of
radiation treatment (n= 141). Patients were given a letter
inviting them to participate, a copy of the questionnaire and
a return envelope. They were asked to fill in the questionnaire
within the next 3 days. The questionnaire was returned by 98
of these patients (70%).
The Scottish sample involved 134 cancer patients that were
treated with radiotherapy at the Western General Hospital in
1. I feel fit
Edinburgh. They were invited to fill in the questionnaire
either at the department in the waiting area, or at home. In
the latter case, they were instructed to complete the forms on
their own, within 24 h. Eighteen patients (13%) failed to
return the questionnaire, resulting in a final sample of 116
patients.
Instruments
The MFI-20 consists of five scales, based on different modes
of expressing fatigue. 'General fatigue' includes general
statements concerning a person's functioning such as 'I feel
rested'. 'Physical fatigue' refers to the physical sensation
related to the feeling of tiredness. Possible somatic symptoms
of fatigue such as light-headedness or sore muscles are not
included in this scale in order to exclude as much as possible
contamination with the symptoms of somatic illness,
independent of fatigue. Reduction in activities and lack of
motivation to start any activity are covered by the scales
'reduced activities' and 'reduced motivation' respectively.
Finally, cognitive symptoms such as having difficulties
concentrating are included in the scale for 'mental fatigue'.
Each scale contains four items for which the person had to
indicate on a seven-point scale to what extent the particular
statement applies to him or her. An equal number of items is
worded in a positive and in a negative direction to counteract
response tendencies. A sample from each of the five scales is
presented in Figure 1.
The MFI-20 was translated into English by a Dutch
professional translator and a native English speaker with a
thorough knowledge of Dutch. Both versions were compared
and revised by the English investigator. This version was then
sent back to the first author, and a final version was made in
collaboration with the professional translator.
Besides the MFI, the questionnaire in both studies
included the Rotterdam Symptom Checklist (RSCL). This
instrument is developed to assess the physical and
psychological symptoms experienced by cancer patients, as
well as the patient's activities of daily living and overall
quality of life (de Haes et al., 1990).
The Scottish patients also completed the Hospital Anxiety
and Depression Scale (HADS). The HADS is a self-report
questionnaire developed to assess anxiety and depression for
use in non-psychiatric hospital settings (Zigmond and Snaith,
1983). A major advantage of this questionnaire over many
other depression scales is that it has no items referring
directly to feelings of tiredness or sleepiness, which most
likely would contaminate the relation with a fatigue
Yes, that is l l lNo, that is
true not true
2. Physically I feel only able to do a little
3. feel very active
4. 1 am not up to much




Yes, that is l l l | No,that is
true l not true
Yes, that is | l l INo,that is
true not true
Yes, that is | l l l INo, that is
true l l l l not true
1 Investigators interested in using the instrument should contact the first author. For academical use, permission will be
granted at no charge, but while still under development, investigators will be requested to share their results with the
instrument so that reliability and validity testing can proceed appropriately.
2Based on the response distribution obtained in the studies presented in this paper and in prior investigations, the
response format in the latest version of the MFI-20 has been changed from a seven to a five-point scale.
Figure 1 Examples of items included in the MFI.
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Iquestionnaire. The only item which may refer to fatigue is the
item 'I feel as if I am slowed down'. Patients had to indicate
their fatigue on a visual analogue scale (VAS) covering the
overall intensity of fatigue experienced during the previous
days, by placing a mark on a 100 mm line with two end
points: 'not at all tired' and 'extremely tired'.
Statistical methods
Confirmatory factor analyses were performed to investigate
the structure of the MFI-20. An advantage of confirmatory
factor analysis over exploratory factor analysis is that the
investigator may specify beforehand the kind of interpreta-
tion preferred on theoretical grounds. To assess to which
degree and probability the hypothesised model fitted the data,
Lisrell's VII unweighted least-squares method was used
(J6rekog and Sorbom, 1988). As in the previous studies, it
was assumed that fatigue can best be described with five
dimensions. Indices of the fit of the model include the chi-
square statistic, the goodness of fit index (GFI) and the
adjusted goodness of fit index (AGFI). A model that fits the
data will have a low chi-square statistic and high GFI and
AGFI. The latter two can range from 0 to 1, with indexes of
0.90 or higher indicating a good fit.
Cronbach's alpha coefficients were calculated for the
separate scales, for both samples. The alpha coefficient
provides an indication of internal consistency, that is the
degree of convergence between different items hypothesised to
represent the same construct.
Convergent validity refers to the extent to which different
ways of measuring the same trait intercorrelate with one
another. Convergent validity of the MFI-20 was determined
in the Scottish sample by correlating the scales with the VAS.
Since the VAS measures a global sensation of fatigue it was
expected that the highest correlations would be obtained with
the MFI-scale for general fatigue.
Construct validity is evaluated by testing hypotheses about
how the instrument should behave. Fatigue is frequently
associated with a reduction in activity level. Therefore, an
indication of the validity of the instrument was provided by
its correlation with the RSCL scale measuring activities of
daily living (ADL). A moderate but significant correlation
was expected, in particular for the MFI-scale of reduced
activity.
Fatigue is also generally acknowledged to be related to
negative emotions, in particular depression. Therefore,
correlation coefficients were calculated with the HADS
scales, assuming a high correlation with both scales, but
more so for depression than for anxiety. It was also
hypothesised that the association with depression would be
strongest for the MFI scale of reduced motivation. In order
to investigate whether an association beween fatigue and
depression would primarily result from the overlap in item
content, analyses involving the depression scale were
performed twice: once with the total score and once with
the exclusion of the item 'I feel as if I am slowed down'.
To investigate whether the MFI-20 is capable of
distinguishing between groups with different fatigue inten-
sities, two groups were formed based on the scores on the
RSCL item 'tiredness'; those who report no or little tiredness,
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and those who report moderate or very much tiredness.
Differences in mean MFI scores were tested using univariate
analyses of variance.
Results
Characteristics of the patients
The Dutch sample included 52 women (54%) and 45 men
(46%). Their average age was 61 years (range: 20-88). The
most frequent diagnoses were cancer of the lungs (28%) and
breast (19%). The majority of patients in the Scottish sample
was female (88 women=77% and 28 men=23%). The
average age was 57 years (range: 14-85). The two most
prevalent diagnoses in this sample were breast cancer (46%)
and cancer of the urogenital tract (13%).
Intensity offatigue
An indication of the intensity of fatigue in these samples is
obtained by the frequency distribution of responses to the
items tiredness and lack ofenergy in the RSCL. In the Dutch
sample 54% of the patients reported moderate or severe
tiredness and 31% lack of energy. In the Scottish sample
these percentages were 40% and 35% respectively. In both
samples these percentages were higher than for any of the
other somatic symptoms included in the questionnaire.
Psychometric properties of the MFI-20
The confirmatory factor analyses resulted in an AGFI of 0.98
(chi-square 528.11, d.f.=160) in the Dutch sample and 0.97
(chi-square 364.84, d.f.=160) in the Scottish sample. Both
these AGFIs are well above 0.90, which indicates a good fit
of the five-factor model on the data. These findings confirm
the appropriateness of distinguishing five dimensions of
fatigue in the MFI. The intercorrelations of these scales are
presented in Table I.
Regarding the internal consistency, the Cronbach's alphas
(Table II) are good (>0.75) to excellent (>0.90) for these
five scales in both samples.
Convergent validity of the MFI-20 in the Scottish sample
was substantiated, as correlations between the separate scales
and the VAS are all significant (P<0.001), as expected. The
correlations were 0.83 for general fatigue, 0.71 for physical
fatigue, 0.67 for reduced activity, 0.61 for reduced motivation
and 0.54 for mental fatigue. As hypothesised, the scale for
general fatigue had the highest correlation with the VAS.
Construct validity was assessed next, for each of the MFI
scales. Results regarding the correlations with activities of
daily living and emotional distress are presented in Table III,
for both samples. The significant correlations between the
first four MFI scales and the ADL scale confirm the
expectations. It was also assumed that the strongest relation
would be obtained with reduced activity. This assumption is
only partly supported. In both samples, the relationships
between the first four fatigue dimensions and the scale for
activities of daily living are similar. Only mental fatigue has
substantially lower correlation coefficients.
As expected, the associations between anxiety and
depression and fatigue are significant. The relation with
Table I Intercorrelations between the separate MFI scales for the Dutch and Scottish samples
Dutch sample Scottish sample
n=90 n=107
1 2 3 4 5 1 2 3 4 5
1. General fatigue - -
2. Physical fatigue 0.86** - 0.84**
3. Reduced activity 0.78** 0.87** - 0.79** 0.73**
4. Reduced motivation 0.72** 0.76** 0.77** 0.71** 0.66** 0.76**
5. Mental fatigue 0.38** 0.30* 0.39** 0.36** - 0.58** 0.53** 0.55** 0.53**
*P<0.01, **P<0.001.MFI-20 in cancer patients receiving radiotherapy
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Table II Descriptive information for the separate MFI scales in the Dutch and Scottish samples: mean scores, standard deviations,
percentage with maximum and minimum scores and Cronbach's alphas
Dutch sample Scottish sample
Percentage Percentage Percentage Percentage
with maxi- with minimum Cronbach's with maxi- with minimum Cronbach's
Mean s.d. mum score score alpha Mean s.d. mum score score alpha
General fatigue 19.9 8.5 28.6 9.2 0.93 15.8 8.2 9.7 11.2 0.85
Physical fatigue 18.2 8.8 16.3 11.2 0.90 14.2 7.6 3.7 14.2 0.79
Reduced activity 19.4 8.5 23.5 10.2 0.89 17.2 8.5 15.7 10.4 0.87
Reduced motivation 17.3 8.4 15.3 12.2 0.83 11.9 7.3 4.5 19.4 0.79
Mental fatigue 14.2 8.0 10.2 17.3 0.82 11.1 8.2 5.2 33.6 0.89
Table III Correlations between MFI scales and activities of daily living (RSCL); anxiety and depression (HADS)
Dutch sample Scottish sample
ADL ADL Anxiety 95% confidence Depression 95% confidence Depression
n=61 n=76 n = 108 interval' n= 109 interval' minus item 8
General fatigue 0.58** 0.42** 0.51** 0.36<0.64 0.77** 0.67<0.83 0.67**
Physical fatigue 0.71** 0.44** 0.45** 0.28<0.59 0.67** 0.70<0.85 0.56**
Reduced activity 0.67** 0.43** 0.40** 0.23<0.55 0.70** 0.59<0.78 0.62**
Reduced motivation 0.59** 0.37* 0.41** 0.25<0.56 0.71** 0.61 <0.79 0.67**
Mental fatigue 0.28 0.19 0.52** 0.37<0.65 0.61** 0.48<0.72 0.58**
aConfidence intervals are calculated using Fischer's Z-transformation procedure. *P<0.01, ***P<0.001.
Table IV Mean scores for the MFI scales for 'tired' and 'not tired' patients as indicated by their scores on the RSCL item 'tiredness'
Dutch sample (n=94) Scottish sample (n= 109)
Not tired Tired Not tired Tired
Mean s.d. Mean s.d. Mean s.d. Mean s.d.
General fatigue 12.68 7.09 25.45* 4.17 10.38 6.84 21.36* 5.14
Physical fatigue 16.22 11.57 34.10* 7.83 10.04 6.48 18.31* 6.33
Reduced activity 15.51 8.97 29.32* 6.55 12.30 7.80 21.96* 6.07
Reduced motivation 11.79 7.17 21.80* 6.37 8.43 5.10 15.71* 7.48
Mental fatigue 14.48 9.13 19.51 9.88 7.83 5.76 14.42* 8.92
*The difference in mean score between 'not tired' and 'tired' patients is significant (P< 0.001).
depression is stronger than the relation with anxiety. The
confidence intervals demonstrate that the differences in
correlations between anxiety and depression are most likely
significant, except for mental fatigue. This finding also
supports our hypothesis. The assumption that the associa-
tion with depression would be strongest for reduced
motivation is not supported by the data. The relationship is
of similar strength for all five scales. The exclusion of the
item 'I feel as if I am slowed down' from the HADS
depression scale results in a decrease of the correlations for
all five scales. This change in correlation coefficients is greater
than with the removal of any of the other items of the
depression scale.
The average scores of the MFI scales for 'tired' vs 'not
tired' patients in both samples, are presented in Table IV.
The differences in MFI scale scores between these two
groups are all significant with the exception of the scores on
mental fatigue in the Dutch sample.
Discussion
The results favour the psychometric properties of the MFI-
20. Its hypothesised structure of five dimensions is supported
in both samples. The internal consistencies of the resulting
scales are all highly satisfactory.
Both convergent and construct validity of the MFI-20
were assessed in these studies. Convergent validity of the
English version of the MFI-20 was supported by the
significant correlations with the VAS in the Scottish sample.
A similar result was obtained in a previous study involving
Dutch radiotherapy patients in which the MFI was correlated
with a VAS (Smets et al., 1995).
Construct validity is satisfactory across both samples as
indicated by the significant correlations with the daily activity
scores, depression and anxiety. The direction of these
relations is as anticipated: a higher fatigue score is associated
with a reduction in activity and with increased emotional
distress.
The findings in the Dutch and Scottish samples regarding
structure, internal consistency and validity of the instrument
are very similar. This suggests that cancer patients from
different cultural and linguistic backgrounds respond to
rating their fatigue in a similar fashion. However, the result
show differences between the two samples in average scale
scores. First, these differences might reflect cultural differ-
ences in item content or item endorsement, and do not reflect
a true difference in fatigue experience. Another explanation is
based on the difference in the distribution of diagnoses
between the two samples. Almost half of the Scottish sample
consists of women with breast cancer, whereas a quarter of
the Dutch sample consists of patients with carcinoma of the
lungs. It is our experience that lung cancer patients are
generally more fatigued than breast cancer patients. Two final
explanations come with the difference in data accrual
procedure between both samples. Dutch patients were all
approached during the last week of their treatment when
fatigue was assumed to be at its peak. The Scottish sample
included patients at different moments of the treatment
process, presumably representing a greater variety of fatigue
intensities, which could be reflected in lower average scores.
The floor and ceiling scores for the two samples as reported
in Table II show that the percentage of patients with the
maximum score of 28 is higher in the Dutch sample, as
expected. However, the standard deviations for the two
samples are similar. This indicates that the overall
distribution of scores in the two groups is similar. It appears
that the Dutch sample includes a subgroup with extreme
maximum scores.MFI-20 i cancer palseM reun Iolbeqy
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Another difference in procedure concerned the fact that
the Dutch patients were asked to complete the questionnaire
at home, within 3 days, whereas the majority of the Scottish
patients completed the questionnaire at the radiotherapy
department, immediately after being invited to participate.
This procedural difference may explain the lower response
rate in the Dutch sample (70% vs 87%) and may have
resulted in selective drop-out of the least fatigued patients.
Unfortunately, for ethical reasons, no information was
available on the non-responders.
Two additional findings from the studies presented require
discussion. First, with the exception of mental fatigue, all
MFI scales behave more or less similarly. In general, the
correlations between the separate MFI scales and with other
measures do not differ significantly from each other.
Consequently, although the MFI-20 consists of separate
dimensions, as indicated by the confirmatory factor analyses,
four of these dimensions appear to be equally important for
the fatigue experience of cancer patients receiving radio-
therapy. The similarity in their relation with other constructs,
and the high inter-scale correlations suggest that maybe the
distinction between at least some of these dimensions is not
so relevant. Similar results have been found in previous
investigations. For the moment, however, we have decided to
retain the five scales until more information is available on
the behaviour of the separate scales in other patient
populations and in relation to other constructs. If it turns
out that using separate scales does not provide additional
information, scales may be combined in a revised version of
the questionnaire.
The second point in need ofdiscussion is the magnitude of
the correlations of the MFI scales with depression. Even with
the removal of an item from the depression scale because of
its reference to fatigue the correlations remain substantial.
This raises the issue of whether the MFI-20 is capable of
discininating between fatigue and depression. The relation
between fatigue and depression is notoriously complicated
and has attracted a lot of attention in the literature in
particular with respect to the chronic fatigue syndrome. In
cancer, feelings of depression may result from the fact that
one has a possibly fatal disease, and a depressed state of
mind may induce fatigue. However, depression could not
only be a cause, but also a result of persistent feelings of
tiredness. Loss of function and loss of energy resulting
directly from the disease or its treatment may have its adverse
consequences. Finally, depression and fatigue may co-occur
in cancer because both result from the same biological factors
(Hayes, 1991). Additional research is required to assess
discriminant validity of the MFI scales with regard to
depression in cancer patients. A design would be needed
with repeated measurements in a situation in which one
would expect fatigue and depression to change in different
directions or at least to a different degree. Unfortunately,
such situations are scarce. However, if the results of fatigue
and depression diverge, this would support the validity of the
fatigue instrument, although we would always expect to find
a significant association between fatigue and depression. As
indicated, future research with the MFH should address its
discriminant validity with respect to depression. It should
also address the instrument's responsiveness to change.
Sensitivity is an important attribute of a symptom
questionnaire when it is to be used in clinical trials. The
currently used cross-sectional design does not provide any
information on the sensitivity of the scales. Investigating
responsiveness to change would require a longitudinal design
in which change in fatigue levels is expected as a result of
treatment or disease progression. Our previous study in
healthy subjects demonstrated that the scale for general
fatigue is most sensitive to changes in fatigue level.
Future use of the instrument in other cancer patient
populations, other patient groups or non-patient populations
has to result in normative data that help to interpret scale
scores and scale score differences.
So far, the results regarding the structure, the inter-scale
relations and internal consistencies of the MFI scales are in
line with the results obtained in the psychometric studies
performed previously (Smets et al., 1995). Again the scale for
mental fatigue behaves somewhat differently than the other
scales. The resemblance in results indicates that the portrayal
of fatigue using the MFI-20 is quite robust. Its use for
descriptive purposes will hopefully contribute to a better
conceptual understanding of this complex experience in
cancer patients. In clinical practise the possibility of
obtaining a profile of fatigue might help to identify
subgroups of patients who are particularly at risk for certain
'types' of fatigue, and it may enhance the ability to plan and
evaluate therapy. When, for example in clinical trials, a short
instrument is required, it could be argued that only the scale
for general fatigue is used.
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